SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-035596
Filing Date
2023-10-31
Accepted
2023-10-31 07:02:06
Documents
15
Period of Report
2023-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20231031.htm   iXBRL 8-K 25938
2 EX-99.1 ardx-20230930xexhibit991.htm EX-99.1 110597
6 ardx-20231031_g1.jpg GRAPHIC 2570
7 image_0a.jpg GRAPHIC 2381
  Complete submission text file 0001628280-23-035596.txt   289484

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20231031.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20231031_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20231031_pre.xml EX-101.PRE 13046
9 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20231031_htm.xml XML 2892
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 231362243
SIC: 2834 Pharmaceutical Preparations